(Q41150726)

27 September 2017

Two aromatic residues regulate the response of the human oxytocin receptor to the partial agonist arginine vasopressin (English)

1 reference

27 September 2017

0 references

1 reference

1

1 reference

27 September 2017

Mouillac B

2

1 reference

27 September 2017

Balestre MN

3

1 reference

27 September 2017

Trumpp-Kallmeyer S

4

1 reference

27 September 2017

Hoflack J

5

1 reference

27 September 2017

Hibert M

6

1 reference

27 September 2017

Andriolo M

7

1 reference

27 September 2017

Pupier S

8

1 reference

27 September 2017

Jard S

9

1 reference

27 September 2017

Barberis C

10

1 reference

27 September 2017

language of work or name

English

0 references

publication date

1 November 1996

1 reference

27 September 2017

6

1 reference

based on heuristic

inferred from page(s)

published in

FEBS Letters

1 reference

27 September 2017

397

1 reference

27 September 2017

2-3

1 reference

27 September 2017

201-206

1 reference

Neurohypophysial peptide systems: processing machinery, hydroosmotic regulation, adaptation and evolution

27 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2896%2901135-0

Structure and expression of a human oxytocin receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2896%2901135-0

Structure, characterization, and expression of the rat oxytocin receptor gene.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2896%2901135-0

Molecular cloning and expression of a rat V1a arginine vasopressin receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2896%2901135-0

Extrapituitary expression of the rat V1b vasopressin receptor gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2896%2901135-0

Molecular cloning of the receptor for human antidiuretic hormone

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2896%2901135-0

Cloning and characterization of a vasopressin V2 receptor and possible link to nephrogenic diabetes insipidus

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2896%2901135-0

Structure, function, and phylogeny of [Arg8]vasotocin receptors from teleost fish and toad

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2896%2901135-0

Teleost isotocin receptor: structure, functional expression, mRNA distribution and phylogeny

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2896%2901135-0

A novel G protein-coupled receptor mediating both vasopressin- and oxytocin-like functions of Lys-conopressin in Lymnaea stagnalis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2896%2901135-0

The binding site of neuropeptide vasopressin V1a receptor. Evidence for a major localization within transmembrane regions

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2896%2901135-0

An extracellular residue determines the agonist specificity of V2 vasopressin receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2896%2901135-0

125I-labelled d(CH2)5[Tyr(Me)2,Thr4,Tyr-NH2(9)]OVT: a selective oxytocin receptor ligand.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2896%2901135-0

LIGAND: A versatile computerized approach for characterization of ligand-binding systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2896%2901135-0

Lithium amplifies agonist-dependent phosphatidylinositol responses in brain and salivary glands

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2896%2901135-0

Synthesis and some pharmacological properties of [4-threonine, 7-glycine]oxytocin, [1-(L-2-hydroxy-3-mercaptopropanoic acid), 4-threonine, 7-glycine]oxytocin (hydroxy[Thr4, Gly7]oxytocin), and [7-Glycine]oxytocin, peptides with high oxytocic-antidiu

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2896%2901135-0

Human myometrium during pregnancy contains and responds to V1 vasopressin receptors as well as oxytocin receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2896%2901135-0

Efficacy of beta 1-adrenergic receptors is lower than that of beta 2-adrenergic receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2896%2901135-0

Factors determining specificity of signal transduction by G-protein-coupled receptors. Regulation of signal transfer from receptor to G-protein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2896%2901135-0

Molecular characterization of a cloned human oxytocin receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2896%2901135-0

Modeling of G-protein-coupled receptors: application to dopamine, adrenaline, serotonin, acetylcholine, and mammalian opsin receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2896%2901135-0

Nephrogenic diabetes insipidus: an X chromosome-linked dominant inheritance pattern with a vasopressin type 2 receptor gene that is structurally normal

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2896%2901135-0

Molecular biology of diabetes insipidus

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2896%2901135-0

Structure and function of receptors coupled to G proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2896%2901135-0

Locating ligand-binding sites in 7TM receptors by protein engineering.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2896%2901135-0

This is not a G protein-coupled receptor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2896%2901135-0

Structure and function of G protein-coupled receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2896%2901135-0

Agonist-receptor efficacy. I: Mechanisms of efficacy and receptor promiscuity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2896%2901135-0

Tyr115 is the key residue for determining agonist selectivity in the V1a vasopressin receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2896%2901135-0

A role for phosphoinositide hydrolysis in human uterine smooth muscle during parturition

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2896%2901135-0

Oxytocin- and vasopressin-binding sites in the rat uterus: competition binding and inhibitory pA2 studies with oxytocin and oxytocin antagonists

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2896%2901135-0

Oxytocin activates the inositol-phospholipid-protein kinase-C system and stimulates prostaglandin production in human amnion cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2896%2901135-0

The docking of Arg2 of angiotensin II with Asp281 of AT1 receptor is essential for full agonism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2896%2901135-0

10.1016/S0014-5793(96)01135-0

7 January 2021

Identifiers

DOI

1 reference

27 September 2017

1 reference